Product NDC: | 51079-224 |
Proprietary Name: | Diclofenac Sodium |
Non Proprietary Name: | diclofenac sodium |
Active Ingredient(s): | 75 mg/1 & nbsp; diclofenac sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51079-224 |
Labeler Name: | UDL Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075281 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100604 |
Package NDC: | 51079-224-20 |
Package Description: | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-224-20) > 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (51079-224-01) |
NDC Code | 51079-224-20 |
Proprietary Name | Diclofenac Sodium |
Package Description | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-224-20) > 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (51079-224-01) |
Product NDC | 51079-224 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | diclofenac sodium |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20100604 |
Marketing Category Name | ANDA |
Labeler Name | UDL Laboratories, Inc. |
Substance Name | DICLOFENAC SODIUM |
Strength Number | 75 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |